Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.
Basu
Anamika
A
Center for Health Disparities and Molecular Medicine, Loma Linda University School of Medicine, Loma Linda, California 92350, USA.
Banerjee
Hiya
H
Rojas
Heather
H
Martinez
Shannalee R
SR
Roy
Sourav
S
Jia
Zhenyu
Z
Lilly
Michael B
MB
De León
Marino
M
Casiano
Carlos A
CA
D000230:Adenocarcinoma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D000368:Aged; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D045744:Cell Line, Tumor; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D020411:Oligonucleotide Array Sequence Analysis; D061105:Peroxiredoxin III; D054464:Peroxiredoxins / Q000235:genetics* / Q000378:metabolism; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D012333:RNA, Messenger / Q000378:metabolism; D046888:Tissue Array Analysis; D015854:Up-Regulation
D014408:Biomarkers, Tumor; D012333:RNA, Messenger; C516115:PRDX3 protein, human; C515980:PRDX4 protein, human; D061105:Peroxiredoxin III; D054464:Peroxiredoxins; D017430:Prostate-Specific Antigen